Universal health care needed to end HIV epidemic in the USA

Lancet HIV. 2021 Feb;8(2):e63-e64. doi: 10.1016/S2352-3018(20)30342-8. Epub 2020 Dec 22.

Authors

William C Goedel¹, Brandon D L Marshall², Alison P Galvani³

Affiliations

¹ Department of Epidemiology, School of Public Health, Brown University, Providence, RI 02912, USA. Electronic address: william_goedel@brown.edu.
² Department of Epidemiology, School of Public Health, Brown University, Providence, RI 02912, USA.
³ Center for Infectious Disease Modeling and Analysis, School of Public Health, Yale University, New Haven, CT, USA.

PMID: 33357503
DOI: 10.1016/S2352-3018(20)30342-8

No abstract available

MeSH terms

Anti-HIV Agents / economics*
Anti-HIV Agents / therapeutic use
Emtricitabine / economics*
Emtricitabine / therapeutic use
Epidemics / economics
Epidemics / prevention & control*
Female
HIV Infections / drug therapy
HIV Infections / epidemiology*
HIV Infections / virology
Health Services Needs and Demand / economics
Health Services Needs and Demand / ethics*
Healthcare Disparities / economics
Healthcare Disparities / ethics
Humans
Male
Tenofovir / economics*
Tenofovir / therapeutic use
United States / epidemiology
Universal Health Care

Substances

Anti-HIV Agents
Tenofovir
Emtricitabine